Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 5, 2019
Pfenex Earns $11 Million Development Milestone under its Development and License Agreement with Jazz Pharmaceuticals
SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that it has earned an $11 million development milestone under ...
September 4, 2019
Tyme Technologies to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright on September 9, 2019
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will ...
September 4, 2019
DURECT to Present at the 21st Annual Rodman and Renshaw Global Investment Conference Sponsored by H.C. Wainwright
CUPERTINO, Calif., Sept. 4, 2019 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that James E. Brown, Chief Executive Officer will be presenting at the 21st Annual Global ...
September 4, 2019
Vermillion Announces Two Independent Publications Showing OVA1® (MIA- Multivariate Index Assay) Demonstrates Improved Ovarian Malignancy Risk Detection in African-American Women
Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced the publication of two independent studies demonstrating that OVA1® (Blood Multivariate ...
September 4, 2019
Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)
PITTSBURGH, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing medicines to treat rare skin diseases, today announced ...
September 4, 2019
Spring Bank Announces $20 Million Strategic Debt Financing Agreement with Pontifax Medison Finance
HOPKINTON, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
September 4, 2019
aTyr Pharma to Present at the H.C. Wainwright 21st Annual Global Investment Conference
SAN DIEGO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based ...
September 4, 2019
iCAD’s ProFound AI Wins “Best New Radiology Solution” in 2019 MedTech Breakthrough Awards
NASHUA, N.H., Sept. 04, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (“iCAD”) (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced ...
September 4, 2019
Paratek Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference
BOSTON, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today ...
September 4, 2019
Foamix Announces Issuance of New U.S. Patent Covering A Method of Treating Acne that Expires in 2037
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company ...
September 4, 2019
Cellectar Announces Late-Breaker Poster Presentation at the 17th International Myeloma Workshop
FLORHAM PARK, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
September 4, 2019
PolarityTE Appoints Peter Cohen as Chairman of the Board
SALT LAKE CITY, Sept. 4, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the appointment of ...
September 4, 2019
Checkpoint Therapeutics to Present at September 2019 Investor Conferences
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
September 4, 2019
Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
WARREN, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, ...
September 4, 2019
Neovasc to Present at the H.C. Wainwright 21st Annual Global Investment Conference
VANCOUVER , Sept. 4, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
September 4, 2019
Inventiva achieves a major milestone by completing patient recruitment for its Phase IIb clinical study with lanifibranor in NASH
Daix (France), September 4, 2019 – Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas ...
September 4, 2019
Pfenex Appoints Dr. Steve Kay to Scientific Advisory Board
SAN DIEGO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex ...
September 4, 2019
Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting
PALO ALTO, Calif., Sept. 4, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, ...
August 21, 2019
Tetra Bio-Pharma Announces Joint Venture with Thorne and Onegevity Health to Form CB2 Therapeutics
OTTAWA, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (TBP.V) (TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics, today announced it ...
August 21, 2019
Pluristem Therapeutics to Host Key Opinion Leader Call on its Acute Radiation Syndrome and Hematological Deficiencies Programs
HAIFA, Israel, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today ...
Page 11 of 169